These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12090476)

  • 1. FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: an immunohistochemical and image analysis study.
    Mady HH; Melhem MF
    Clin Exp Metastasis; 2002; 19(4):351-8. PubMed ID: 12090476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
    World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of E2F-4 gene in colorectal adenocarcinoma and corresponding covering mucosa: an immunohistochemistry, image analysis, and immunoblot study.
    Mady HH; Hasso S; Melhem MF
    Appl Immunohistochem Mol Morphol; 2002 Sep; 10(3):225-30. PubMed ID: 12373148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of fragile histidine triad expression in colorectal carcinoma.
    Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma.
    Li H; Zhao P; Lu Y; Lu Y
    Int J Colorectal Dis; 2012 Aug; 27(8):1015-20. PubMed ID: 22315171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
    Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
    Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
    Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
    Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
    Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of nuclear factor-kappa-B/P65 and fragile histidine triad in colorectal carcinoma and clinical significance thereof].
    Lü Y; Liu L; Zhao P
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):610-4. PubMed ID: 18646716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer.
    Toledo G; Sola JJ; Lozano MD; Soria E; Pardo J
    Mod Pathol; 2004 Apr; 17(4):440-8. PubMed ID: 14976524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients.
    Zhao P; Liu W; Lu YL
    World J Gastroenterol; 2005 Sep; 11(36):5735-8. PubMed ID: 16237777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features and FHIT gene expression in sporadic colorectal adenocarcinomas.
    Luceri C; Guglielmi F; De Filippo C; Caderni G; Mini E; Biggeri A; Napoli C; Tonelli F; Cianchi F; Dolara P
    Scand J Gastroenterol; 2000 Jun; 35(6):637-41. PubMed ID: 10912665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the FHIT gene in human colorectal cancer is independent of high-risk HPV infection.
    Yu HG; Shun LB; Luo HS; Huang H; Yu BP; Yu JP; Meier JJ; Schrader H; Bastian A; Schmitz F; Schmidt WE
    Int J Colorectal Dis; 2002 Nov; 17(6):396-401. PubMed ID: 12355215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
    Segawa T; Sasagawa T; Saijoh K; Inoue M
    Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
    Yao CC; Lin CY; Hu MB
    Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of galectin-3 expression in colorectal cancer progression and metastasis.
    Nakamura M; Inufusa H; Adachi T; Aga M; Kurimoto M; Nakatani Y; Wakano T; Nakajima A; Hida JI; Miyake M; Shindo K; Yasutomi M
    Int J Oncol; 1999 Jul; 15(1):143-8. PubMed ID: 10375607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
    Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
    World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.
    Mimori K; Ishii H; Nagahara H; Sudo T; Yamashita K; Inoue H; Barnard GF; Mori M
    Cancer Res; 2006 Mar; 66(5):2683-90. PubMed ID: 16510588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
    Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
    Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.